Oramed Pharmaceuticals Inc.
ORMP
$2.12
-$0.05-2.30%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -25.03% | -7.95% | -0.26% | -6.83% | -13.51% |
| Total Receivables | 193.75% | -- | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | -23.88% | -51.67% | 172.36% | -11.07% | 6.39% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | -24.68% | -8.20% | 0.31% | -6.85% | -13.45% |
|
|
|||||
| Total Current Assets | -24.68% | -8.20% | 0.31% | -6.85% | -13.45% |
| Net Property, Plant & Equipment | 50.74% | -8.90% | -7.64% | -9.54% | -6.73% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -18.12% | 16,135.29% | 6.25% | 6.67% | -16.67% |
| Total Assets | 9.59% | -4.98% | -5.94% | -10.39% | -9.54% |
|
|
|||||
| Total Accounts Payable | 40.47% | -35.49% | -84.20% | 43.41% | 174.90% |
| Total Accrued Expenses | 11.83% | -31.30% | 4,117.14% | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 45.86% | -16.20% | -11.11% | -2.80% | -1.57% |
| Total Finance Division Other Current Liabilities | -58.29% | 18.23% | -- | -- | -- |
| Total Other Current Liabilities | -58.29% | 18.23% | -- | -- | -- |
| Total Current Liabilities | -32.76% | -3.39% | 7.81% | 41.25% | -88.88% |
|
|
|||||
| Total Current Liabilities | -32.76% | -3.39% | 7.81% | 41.25% | -88.88% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 440.00% | -23.08% | -16.13% | -21.19% | -13.24% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 84.95% | -50.29% | -0.24% | 0.00% | -0.07% |
| Total Liabilities | 5.96% | -23.02% | 3.89% | 18.47% | -78.73% |
|
|
|||||
| Common Stock & APIC | 0.13% | 0.68% | 0.00% | -0.31% | 0.38% |
| Retained Earnings | 7.21% | -4.33% | -6.12% | -13.36% | 5.90% |
| Treasury Stock & Other | -- | -- | -- | -- | -- |
| Total Common Equity | 9.74% | -3.73% | -6.50% | -11.65% | 6.26% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 9.74% | -3.73% | -6.50% | -11.65% | 6.26% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -3.05% | 0.00% | 0.11% | -0.88% | 0.76% |
| Total Equity | 9.79% | -3.75% | -6.54% | -11.71% | 6.30% |
|
|
|||||